ClinicalTrials.govpublic full text
The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis
ulcerative colitis, colitis, ulcerative, gastrointestinal disease, inflammatory bowel diseases, glucocorticosteroids, anti-inflammatory agents, therapeutic uses, cobitolimod, toll like receptor 9 agonist, tlr9 agonist, kappaproct, idx0150
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 982700
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.